prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
47537,441486009,98426020,70,Eltrombopag 50mg tablets,Eltrombopag olamine,50mg,Tablet,Oral,Drugs Used In Platelet Disorders,August 2012,17847001,,,,,,,,,0,9010400
46465,442045008,98424020,86,Eltrombopag 25mg tablets,Eltrombopag olamine,25mg,Tablet,Oral,Drugs Used In Platelet Disorders,November 2011,17846001,,,,,,,,,0,9010400
69119,1.70752110000e+16,98430020,1,Revolade 50mg tablets (Novartis Pharmaceuticals UK Ltd),Eltrombopag olamine,50mg,Tablet,Oral,Drugs Used In Platelet Disorders,April 2017,17849001,,,,,,,,,0,9010400
77454,1.70755110000e+16,98428020,2,Revolade 25mg tablets (Novartis Pharmaceuticals UK Ltd),Eltrombopag olamine,25mg,Tablet,Oral,Drugs Used In Platelet Disorders,August 2019,17848001,,,,,,,,,0,9010400
71166,449131003,27367021,4,Eltrombopag 75mg tablets,Eltrombopag olamine,75mg,Tablet,Oral,Drugs Used In Platelet Disorders,December 2017,27367021,,,,,,,,,0,9010400
